| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/27/2001 | US6207432 Tyrosylprotein sulfotransferases and methods of use thereof |
| 03/27/2001 | US6207430 Recombinant production; discoloration inhibition in textiles and detergents; polymerization and depolymerization of lignin and derivatives; detoxification of soil; food processing of fruit juice |
| 03/27/2001 | US6207422 Nucleotide sequence coding transmembrane protein associated with ionic mobility; for use in drug screening |
| 03/27/2001 | US6207419 Mutant serpin; for controlling blood coagulation, wound healing, tissue repair and prevent inflammation in humans |
| 03/27/2001 | US6207418 Production of a multimeric protein by cell fusion method |
| 03/27/2001 | US6207417 DNA encoding stem cell factor |
| 03/27/2001 | US6207416 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 03/27/2001 | US6207414 Combining protein or peptide or polypetide with tyrosylprotein sulfotransferase and 3'-phosphoadenosine 5'-phosphosulfate to cause transfer of sulfate from phosphosulfate to tyrosine of the protein or peptide |
| 03/27/2001 | US6207413 Nucleotide sequence coding binding protein; for the diagnosis and treatment of endocrine defects |
| 03/27/2001 | US6207412 Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells |
| 03/27/2001 | US6207411 Bacteriocins |
| 03/27/2001 | US6207410 Nucleotide sequences that code proteins associated with ionic mobility; for the detection of pesticides |
| 03/27/2001 | US6207409 Culturing a recombinant cell that has been transformed with an expression vector having a regulatory sequence and a polynucleotide comprising a dna sequence which endcodes geranyl/geranylpyrophosphate of flavobacterium species |
| 03/27/2001 | US6207407 Identification of antibacterial agents |
| 03/27/2001 | US6207401 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
| 03/27/2001 | US6207399 Methods of determining endogenous thrombin potential (ETP) and thrombin substrates for use in said methods |
| 03/27/2001 | US6207391 High-throughput screening assays for modulators of STAT4 and STAT6 activity |
| 03/27/2001 | US6207390 Incubating target with biotin in mixture, allow biotinylation, incubate heterogenous mix with solid support, incubate with target, monitor preferential binding of avidins |
| 03/27/2001 | US6207389 Methods of controlling T lymphocyte mediated immune responses |
| 03/27/2001 | US6207386 Compositions for the treatment and diagnosis of body weight disorders, including obesity |
| 03/27/2001 | US6207383 Adjusted nucleotide sequences associated with genetic disorder; for the diagnosis, treatment and prevention of arrhythmia |
| 03/27/2001 | US6207375 Peptide for the accurate diagnosis of tumors in mammary glands; anticarcinogenic agents |
| 03/27/2001 | US6207374 Tuberous sclerosis 2 gene and uses thereof |
| 03/27/2001 | US6207200 Administering an antiviral protein to patient infected with human immunodefficiency virus type i |
| 03/27/2001 | US6207169 Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| 03/27/2001 | US6207168 Vaccine composition for herpes simplex virus and methods of using |
| 03/27/2001 | US6207166 Veterinary medicine |
| 03/27/2001 | US6207165 Polynucleotide formula against porcine reproductive and respiratory pathologies |
| 03/27/2001 | US6207162 AspS from Chlamydia trachomatis |
| 03/27/2001 | US6207161 Genetic engineering |
| 03/27/2001 | US6207160 aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies |
| 03/27/2001 | US6207158 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 03/27/2001 | US6207154 Methods of treatment using antagonists of cytokine synthesis inhibitory factor |
| 03/27/2001 | US6207146 Gene expression in mammalian cells |
| 03/27/2001 | US6207144 Polypeptides with interleukin-16 activity, process for the preparation and use thereof |
| 03/27/2001 | CA2201098C Orphan receptor |
| 03/27/2001 | CA2161881C High lysine derivatives of alpha-hordothionin |
| 03/27/2001 | CA2135200C Canine coronavirus s gene and uses therefor |
| 03/27/2001 | CA2123107C Ubiquitin-specific proteases |
| 03/27/2001 | CA2081450C Biologically active peptides containing d-2-alkyltrypthophan |
| 03/27/2001 | CA2076540C Recombinant antibodies specific for tnf-.alpha. |
| 03/27/2001 | CA2065860C Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix |
| 03/27/2001 | CA1341211C Mini-proinsulin, its preparation and use |
| 03/27/2001 | CA1341208C Proteins with factor viii activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them |
| 03/23/2001 | CA2309372A1 Use of antibodies against the nef protein for decreasing the chemotaxis which is induced by retrovirus-infected astrocytes |
| 03/22/2001 | WO2001020531A1 System and method for processing tokenless biometric electronic transmissions using an electronic rule module clearinghouse |
| 03/22/2001 | WO2001020336A2 SCREENING FOR α2δ-1 SUBUNIT BINDING LIGANDS |
| 03/22/2001 | WO2001020038A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 03/22/2001 | WO2001020037A2 Peroxisome proliferator-activated receptor alpha and disorders of lipid metabolism |
| 03/22/2001 | WO2001020033A1 Methods for selecting prostate cancer treatments and treating prostate cancer |
| 03/22/2001 | WO2001020031A2 Polymorphisms in a klotho gene |
| 03/22/2001 | WO2001020026A2 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 03/22/2001 | WO2001020025A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/22/2001 | WO2001020021A2 Complex with specific dephosphorylating enzymes, effectors and method for the production of said complex. |
| 03/22/2001 | WO2001020020A2 Method to identify herbicides, fungicides or plant growth regulators |
| 03/22/2001 | WO2001020012A2 Enhanced plant cell transformation by addition of host genes involved in t-dna integration |
| 03/22/2001 | WO2001020010A2 Transcriptionally silenced plant genes |
| 03/22/2001 | WO2001020009A1 Plants having altered amino acid contents and method for the production thereof |
| 03/22/2001 | WO2001020008A2 Vascular-specific promoters |
| 03/22/2001 | WO2001020006A1 Chemically inducible promoter and method for controlling the expression of a target gene in an eukaryote |
| 03/22/2001 | WO2001019998A1 Novel detoxified mutants of escherichia coli heat-labile enterotoxin |
| 03/22/2001 | WO2001019997A2 Basb128 polypeptide and polynucleotide from moxarella catarrhalis |
| 03/22/2001 | WO2001019996A1 Moraxella catarrhalis antigen, corresponding gene and uses thereof |
| 03/22/2001 | WO2001019995A1 Plant flowering control genes |
| 03/22/2001 | WO2001019994A2 PLANT APOPTOSIS INDUCING FACTORS (AIFs) |
| 03/22/2001 | WO2001019993A2 Virulence genes of m. marinum and m. tuberculosis |
| 03/22/2001 | WO2001019991A1 Compositions and methods for the treatment of immune related diseases |
| 03/22/2001 | WO2001019990A1 Rip-3-like death-associated kinase |
| 03/22/2001 | WO2001019989A2 Method of producing and purifying endostatintm protein |
| 03/22/2001 | WO2001019988A1 Secreted proteins and polynucleotides encoding them |
| 03/22/2001 | WO2001019987A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 03/22/2001 | WO2001019986A1 Peptide leukotriene receptor |
| 03/22/2001 | WO2001019985A1 Novel receptors and genes encoding the same |
| 03/22/2001 | WO2001019984A1 Rgs8like polypeptide and polynucleotides, a member of the regulators of g protein signalling family of polypeptides |
| 03/22/2001 | WO2001019983A1 Human g-protein coupled receptor |
| 03/22/2001 | WO2001019974A2 Recombinant microorganisms |
| 03/22/2001 | WO2001019973A2 Nicotinic acetylcholine receptor: alpha10 subunit |
| 03/22/2001 | WO2001019969A1 A process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 03/22/2001 | WO2001019968A1 Recombinant eggs and gene cloning and expression vectors based on avian adenoviruses |
| 03/22/2001 | WO2001019958A2 Stabilized soluble glycoprotein trimers |
| 03/22/2001 | WO2001019870A2 Secreted soluble alpha2delta-2, alpha2delta-3, alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/22/2001 | WO2001019869A1 Dendritic cell membrane protein cire |
| 03/22/2001 | WO2001019868A1 A novel angiogenesis inhibitor |
| 03/22/2001 | WO2001019867A1 Prion-related protein |
| 03/22/2001 | WO2001019865A1 A novel muskelin and its application and producing method |
| 03/22/2001 | WO2001019864A1 Polynucleotides encoding novel human angiotensin ii-1 receptor proteins and the method of preparation and its use |
| 03/22/2001 | WO2001019863A1 Preparation of highly pure toxin fragments |
| 03/22/2001 | WO2001019862A2 Polypeptides from moraxella (branhamella) catarrhalis |
| 03/22/2001 | WO2001019861A2 Apo-2 receptor antibodies |
| 03/22/2001 | WO2001019860A2 Proteins associated with cell differentiation |
| 03/22/2001 | WO2001019859A2 LEPIDOPTERAN-ACTIVE BACILLUS THURINGIENSIS δ-ENDOTOXIN COMPOSITIONS AND METHODS OF USE |
| 03/22/2001 | WO2001019858A2 A family of ubiquitin-like proteins binds the atpase domain of hsp70-like stch |
| 03/22/2001 | WO2001019857A2 Facilitative transporter (ft1 and ft2) from drosophila melanogaster and uses thereof |
| 03/22/2001 | WO2001019856A2 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | WO2001019855A2 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/22/2001 | WO2001019854A2 Neurotransmitter transporter |
| 03/22/2001 | WO2001019852A2 Methods of peptide preparation |
| 03/22/2001 | WO2001019851A2 Opaminergic neuronal survival-promoting factors and uses thereof |
| 03/22/2001 | WO2001019850A2 Nrage nucleic acids and polypeptides and uses thereof |
| 03/22/2001 | WO2001019847A1 A binding motif of a receptor |